1. Home
  2. SILO vs UPXI Comparison

SILO vs UPXI Comparison

Compare SILO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • UPXI
  • Stock Information
  • Founded
  • SILO 2010
  • UPXI 2018
  • Country
  • SILO United States
  • UPXI United States
  • Employees
  • SILO N/A
  • UPXI N/A
  • Industry
  • SILO Apparel
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • SILO Consumer Discretionary
  • UPXI Health Care
  • Exchange
  • SILO Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • SILO 4.7M
  • UPXI 5.1M
  • IPO Year
  • SILO N/A
  • UPXI 2021
  • Fundamental
  • Price
  • SILO $0.84
  • UPXI $4.54
  • Analyst Decision
  • SILO
  • UPXI Hold
  • Analyst Count
  • SILO 0
  • UPXI 1
  • Target Price
  • SILO N/A
  • UPXI $25.00
  • AVG Volume (30 Days)
  • SILO 596.1K
  • UPXI 138.9K
  • Earning Date
  • SILO 11-12-2024
  • UPXI 12-24-2024
  • Dividend Yield
  • SILO N/A
  • UPXI N/A
  • EPS Growth
  • SILO N/A
  • UPXI N/A
  • EPS
  • SILO N/A
  • UPXI N/A
  • Revenue
  • SILO $72,102.00
  • UPXI $26,000,652.00
  • Revenue This Year
  • SILO $1.86
  • UPXI $18.98
  • Revenue Next Year
  • SILO N/A
  • UPXI $8.09
  • P/E Ratio
  • SILO N/A
  • UPXI N/A
  • Revenue Growth
  • SILO N/A
  • UPXI 27.11
  • 52 Week Low
  • SILO $0.77
  • UPXI $2.17
  • 52 Week High
  • SILO $4.50
  • UPXI $33.00
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.96
  • UPXI 47.41
  • Support Level
  • SILO $0.77
  • UPXI $4.67
  • Resistance Level
  • SILO $0.99
  • UPXI $5.24
  • Average True Range (ATR)
  • SILO 0.10
  • UPXI 0.55
  • MACD
  • SILO 0.00
  • UPXI -0.03
  • Stochastic Oscillator
  • SILO 23.30
  • UPXI 34.39

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About UPXI Upexi Inc.

Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.

Share on Social Networks: